Results 251 to 260 of about 823,424 (276)

A Standardised Model for Stool Banking for Faecal Microbiota Transplantation: A Consensus Report From a Multidisciplinary UEG Working Group

open access: yesUnited European Gastroenterology Journal, 2021
Background: Faecal microbiota transplantation is an emerging therapeutic option, particularly for the treatment of recurrent Clostridioides difficile infection.
Ed J Kuijper   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Faecal microbiota transplantation is promising but not a panacea

Nature Microbiology, 2016
Faecal microbiota transplantation has proved efficacious for diseases such as recurrent Clostridium difficile infection via restoration of gut microbial ecology and bile acid content. However, despite its adoption by mainstream medicine, misuse of this technology in clinical or domestic settings warrants caution.
Michael J, Sadowsky, Alexander, Khoruts
openaire   +2 more sources

Faecal microbiota transplantation

BSAVA Companion, 2018
Transplanting faecal matter from healthy donors could help provide relief for dogs with chronic diarrhoea and for their owners, volunteers with the StreetVet charity were told at a meeting in London.
openaire   +1 more source

Faecal microbiota transplant

Gastrointestinal Nursing, 2012
Faecal microbiota transplant (FMT) is the term used when stool is taken from a healthy individual and instilled into a sick person to cure a certain disease such as recurrent Clostridium difficile infection (CDI). The rationale for FMT lies in the belief that CDI results from an imbalance or disruption of the community of organisms residing in the ...
openaire   +1 more source

No benefit of faecal microbiota transplantation for IBS-D

Drug and Therapeutics Bulletin, 2020
Abstract Review of: Aroniadis OC, Brandt LJ, Oneto C, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol 2019;4:675–85.
openaire   +2 more sources

Faecal microbiota transplantation: Key points to consider

Annales Pharmaceutiques Françaises, 2015
Faecal microbiota transplantation (FMT) from a healthy donor has become the gold standard treatment for patients suffering from recurrent Clostridium difficile infection where antibiotic treatment (with vancomycin, metronidazole or fidaxomicin) has failed. FMT eradicates C. difficile and helps restore the recipient's intestinal flora, but its mechanism
openaire   +2 more sources

Realising the potential of faecal microbiota transplant

Prescriber, 2023
First reported in Western medical literature in the 1950s, faecal microbiota transplant (FMT) has now come of age as a cost‐effective treatment for recurrent Clostridioides difficile infection.
openaire   +1 more source

Time to rethink Blastocystis in faecal microbiota transplantation

Trends in Parasitology
Blastocystis commonly colonises the human gut, but its presence has traditionally led to the exclusion of faecal microbiota transplantation donors. Emerging evidence links it to greater microbial diversity and favourable metabolic profiles, while no harm is seen in immunocompetent recipients.
Anders Krifors   +3 more
openaire   +2 more sources

New guidelines for providing faecal microbiota transplant

Drug and Therapeutics Bulletin, 2019
### Key points New guidelines on faecal microbiota transplant from the British Society of Gastroenterology and Healthcare Infection Society provide recommendations to help standardise and optimise the procedure for treating recurrent Clostridium difficile infections.1 A joint British Society of Gastroenterology (BSG) and Healthcare Infection Society
openaire   +2 more sources

Faecal microbiota transplantation for urinary tract infections

Clinical Microbiology and Infection
Recurrent urinary tract infections (rUTIs) are a major clinical burden, increasingly complicated by multidrug-resistant organisms (MDROs) and antibiotic overuse. Growing evidence implicates gut microbiota dysbiosis as a key contributor to urinary tract infections (UTI) susceptibility, with the gastrointestinal tract acting as a reservoir for ...
Paulína, Belvončíková   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy